SRP9

Signal recognition particle 9 kDa protein · P49458 · SRP9 on Sugi Atlas →

0 patent compounds predicted against SRP9, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SRP9 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 PHASE3ACTIVE_NOT_RECRUITING
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy EARLY_PHASE1RECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Genomic of CONgenital Sideroblastic Anemias nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Testing of Micellar Casein, Blended Micellar Casein and Native Whey nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer nanUNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Study of Constitutional Platelet Disease nanUNKNOWN
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis nanNOT_YET_RECRUITING
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a SRP9 binder may also engage these)

ProteinNameSimilarity
Q4R6I6 1.000 Q4R6I6 →
A4Y6A8 1.000 A4Y6A8 →
A1RK88 1.000 A1RK88 →
B4SVW1 1.000 B4SVW1 →
Q5GT42 1.000 Q5GT42 →
P21262 1.000 P21262 →
Q212F4 1.000 Q212F4 →
Q9SMU7 1.000 Q9SMU7 →
B7VL66 1.000 B7VL66 →
Q9CNI7 1.000 Q9CNI7 →
B5XNF9 1.000 B5XNF9 →
B4TXY3 1.000 B4TXY3 →
Q57ST5 1.000 Q57ST5 →
Q39236 1.000 Q39236 →
B5QTW0 1.000 B5QTW0 →
P21680 1.000 P21680 →
A5WG70 1.000 A5WG70 →
A4VJA8 1.000 A4VJA8 →
P0DJV7 1.000 P0DJV7 →
Q8X7N6 1.000 Q8X7N6 →
Q6ZQV5 1.000 Q6ZQV5 →
P0CK89 1.000 P0CK89 →
A1ANL2 1.000 A1ANL2 →
Q12NR2 1.000 Q12NR2 →
B2GBW6 1.000 B2GBW6 →
P0DJU0 1.000 P0DJU0 →
A9MP50 1.000 A9MP50 →
Q5KWU6 1.000 Q5KWU6 →
B0REG5 1.000 B0REG5 →
B1KDK2 1.000 B1KDK2 →